The National Immunisation Advisory Committee (NIAC) provides evidence-based advice to the Department of Health on vaccinations, immunisation and related health matters. This advice is prepared through extensive review of the latest clinical and scientific information.
- NIAC recommendations for Avian Influenza vaccine (PDF, 433KB) Issued 20 December 2024
- NIAC updated recommendations for pneumococcal conjugate vaccination in childhood (PDF, 1,881KB) Issued 25 October 2024
- NIAC updated recommendations for mpox vaccination (PDF, 415KB) Issued 9 September 2024
- NIAC updated recommendations for COVID-19 primary schedule vaccination (PDF, 647KB) Issued 26 August 2024
- NIAC updated 2024 recommendations for COVID-19 vaccination (PDF, 690KB) Issued 28 May 2024
- NIAC recommendations for the passive immunisation of infants against Respiratory Syncytial Virus (RSV) during the 2024/2025 season (PDF, 277KB) Issued 16 April 2024
- NIAC updated recommendations for the vaccination of adults against measles (PDF, 363KB) Issued 5 March 2024
- NIAC recommendations regarding Spring 2024 COVID-19 vaccination (PDF, 735KB) Issued 15 February 2024
- NIAC recommendations regarding Herpes Zoster vaccine (PDF, 458KB) Issued 12 February 2024
- Updated recommendations for primary series COVID-19 vaccination (PDF, 740 KB) Issued 19 December 2023
- Recommendations for adapted Nuvaxovid vaccine: Nuvaxovid XBB.1.5 (PDF, 192KB) Issued 15 November 2023
- Evidence synthesis and recommendations for passive immunisation and vaccination against Respiratory Syncytial Virus in infants, children and older adults (PDF, 1,077KB) Issued 12 October 2023
- Letter to Chief Medical Officer regarding Comirnaty Omicron XBB.1.5 COVID-19 vaccine (PDF, 283KB) Issued 04 September 2023
- Letter to Chief Medical Officer regarding review of Autumn 2023 COVID-19 booster recommendations (PDF, 754KB) Issued 17 August 2023
- Letter to Chief Medical Officer regarding clarification of evidence relating to CIN1 HPV vaccination (PDF, 259KB) Issued 05 May 2023
- Recommendations for the 2023 COVID-19 vaccination strategy Version 1.1 (PDF, 1,426KB) Issued 11 April 2023
- Letter to Chief Medical Officer regarding timing of administration of COVID-19 booster vaccines in pregnancy (PDF, 250KB) Issued 27 February 2023
- Updated recommendations for immunisation of children aged two months to five years of age (PDF, 1,194KB) Issued 15 February 2023
- Background document regarding additional COVID-19 vaccination for those aged 18-49 years (PDF, 716KB)
Issued 16 January 2023
- Recommendations for COVID-19 vaccination of children aged 6 months to 4 years Version 1.1 (PDF, 543KB)
Issued 16 January 2023
- Letter to Chief Medical Officer regarding bivalent COVID-19 vaccine for children aged 5-11 years (PDF, 179KB) Issued 19 December 2022
- Letter to Chief Medical Officer regarding inclusion of additional cohorts of the population in the booster COVID-19 programme (PDF, 217KB) Issued 19 December 2022
- Updated recommendations regarding bivalent mRNA COVID-19 vaccines (PDF, 756KB) Issued 12 December 2022
- Selective strategy for BCG vaccination (PDF, 682KB) Issued 10 October 2022
- Recommendations regarding Polio Re-emergence (PDF, 467KB) Issued 6 October 2022
- Recommendations regarding HibMenC combination vaccine (PDF, 247KB) Issued 3 October 2022
- Recommendations regarding HPV Vaccine dosage (PDF, 931KB) Issued 6 September 2022
- Recommendations for the use of monkeypox modified Vaccinia Ankara Vaccines, Imvanex or Jynneos, by the intradermal route (PDF, 239KB) Issued 22 August 2022
- Additional COVID-19 booster vaccination (PDF, 999KB) Issued 22 July 2022
- Letter to the Chief Medical Office regarding recommendations for the use of smallpox (vaccinia) vaccine as pre and post exposure prophylaxis against monkeypox (PDF, 215KB)
Issued 22 July 2022
- Letter to Chief Medical Officer regarding post vaccination observation period (PDF, 163KB) Issued 17 June 2022
- Monkeypox vaccination (PDF, 265KB) Issued 27 May 2022
- Updated recommendations for HPV Vaccination (PDF, 748KB) Issued 14 April 2022
- Medium Term Strategy for the COVID-19 Vaccination Programme including Second Booster Dose (PDF, 683KB) Issued 05 April 2022
- Recommendations for COVID-19 booster vaccination of those aged 12-15 years (PDF, 656KB) Issued 18 February 2022
- Letter to the Chief Medical Officer re: recommendations for Nuvaxovid COVID-19 vaccine (Novavax) (PDF, 568KB) Issued 27 January 2022
- Final letter to the Chief Medical Officer re: interval between laboratory-confirmed breakthrough infection and an additional or booster COVID-19 vaccination (PDF, 584KB)
Issued 21 December 2021
- Letter to the Chief Medical Officer re: Waiver of 15-minute observation period post booster COVID-19 mRNA vaccine (PDF, 588KB)
Issued 15 December 2021
- Letter to the Chief Medical Officer re: recommendations for booster interval, and booster vaccination for those with immunocompromise associated with a suboptimal response to vaccines (PDF, 588KB)
Issued 13 December 2021
- Recommendations on COVID-19 vaccination for children aged 5 to 11 Years (PDF, 518KB)
Issued 07 December 2021
- Recommendations on booster doses of COVID-19 vaccine for those aged 16-49 years (PDF, 718KB)
Issued 25 November 2021 | Updated 26 November 2021
- Recommendations on booster doses of COVID-19 vaccine for healthcare workers, 16-59 years with underlying conditions, and all those 50-59 years (PDF, 1MB)
Issued 15 November 2021
- Updated recommendations regarding selection, dose and timing of booster doses of COVID-19 vaccine for those aged 60 years and over (PDF, 165KB)
Issued 03 November 2021
- An Overview of Recommendations regarding booster doses of COVID-19 Vaccine for Healthcare Workers (PDF, 165KB)
Issued 01 November 2021
- NIAC Recommendations regarding booster doses of COVID-19 Vaccine for those aged 60 to 79 years (PDF, 877KB)
Issued 22 October 2021
- NIAC Overview of Recommendations regarding booster doses of COVID-19 Vaccine for those aged 60 to 79 years (PDF, 133KB)
Issued 18 October 2021
- Interim recommendations regarding booster doses of COVID-19 Vaccine for those aged 80 years and older, and those aged 65 and older in long-term care facilities (PDF, 742KB)
Issued 07 September 2021
- Recommendations regarding an additional COVID-19 Vaccine dose for those with immunocompromise associated with a suboptimal response to vaccines (PDF, 393KB)
Issued 30 August 2021
- Updated Recommendations for COVID-19 Vaccination in Pregnancy (PDF, 238KB)
Issued 30 August 2021 | Amended 02 September 2021
- Recommendations for the role of COVID-19 heterologous vaccination in the national programme (PDF, 341KB)
Issued 15 July 2021
- Recommendations on COVID-19 Vaccination for those aged 12-15 years (PDF, 595KB)
Issued 26 July 2021 | Amended 18 August
- Letter to the Chief Medical Officer re: NIAC advice on the potential role of heterologous vaccination and the potential ongoing role of viral vector vaccines as part of the COVID-19 vaccination programme in Ireland (PDF, 235KB)
Issued 28 June 2021
- Recommendations for the second COVID-19 Vaccine dose for those who have already had a first dose of Vaxzevria® (PDF, 404KB)
Published 31 May 2021
- Letter to the Chief Medical Officer about COVID-19 vaccine related issues under consideration (PDF, 247KB)
Issued 24 May 2021
- Recommendations regarding Adenoviral Vector Vaccines (PDF, 542KB)
Published 13 May 2021
- COVID-19 Vaccination after Laboratory confirmed COVID-19 Infection (PDF, 308KB)
Published 26 April 2021 | Updated 29 April 2021
- Recommendations for the use of COVID-19 Vaccines: COVID-19 Vaccine Janssen | Vaxzevria COVID-19 Vaccine AstraZeneca | mRNA Vaccine dose interval (PDF, 840KB)
Published 26 April 2021 | Updated 29 April 2021
- Letter to the Chief Medical Officer about NIAC Recommendations re COVID-19 vaccination (PDF, 196KB)
Issued 29 April 2021
- Recommendations for COVID-19 vaccination in pregnancy (PDF, 243KB)
Published 26 April 2021
- Recommendations for the use of Vaxzevria® COVID-19 Vaccine AstraZeneca (PDF, 329KB)
Published 12 April 2021
- Updated Recommendations: Priority Groups for COVID-19 Vaccination (PDF, 454KB)
Published 29 March 2021
- Recommendations for the use of COVID-19 Vaccine AstraZeneca® (PDF, 246KB)
Published 19 March 2021
- Updated Recommendations for the use of COVID-19 Vaccines (PDF, 256KB)
Published 10 March 2021
- Recommendations for the COVID-19 Vaccination Programme for those aged 65-69 years (PDF, 264KB)
Published 23 February 2021
- Updated Recommendations: Priority Groups for COVID-19 Vaccination (PDF, 310KB)
Published 22 February 2021
- Recommendations for the use of COVID-19 vaccine AstraZeneca® in Ireland (PDF, 249KB)
Published 3 February 2021
- Letter to Chief Medical Officer about Notifications to Norwegian Health Authorities relating to the possible impact of COVID-19 mRNA vaccines on mortality in the frail elderly (PDF, 199KB)
Issued 15 January 2021